Experiential Pharmacogenomic Education for Providers


About this study

The aim of this study is to better understand providers’ attitudes, perceptions and knowledge of pharmacogenomics and to examine the impact of experiential education with providers.  

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • 100 prescribers and pharmacists participating in the Center for Individualized Medicine pharmacogenomic testing pilot studies

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Timothy Curry, M.D., Ph.D.

Open for enrollment

Contact information:

Center for Individualized Medicine


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available